Bridge to Life is a supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion.
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers. The U.S. based company, headquartered in Northbrook, Illinois, is a leading supplier of preservation solutions worldwide with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, it continues to explore emerging science and preservation technologies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 19, 2021 | Series Unknown | $56M | 2 | Perceptive Advisors | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Perceptive Advisors | Yes | Series Unknown |
Peter Maag | — | Series Unknown |